How to create an innovation strategy to achieve a high-value health system
Che L. Reddy, Associate Director, Innovation and Translation, Health Systems Innovation Lab, Harvard University
Rifat Atun, Director, Health Systems Innovation Lab, Harvard University, Professor of Global Health Systems and Vice Dean Non-Degree Education and Innovation, Harvard T.H. Chan School of Public Health, Harvard University

Health systems are strained by changing disease patterns, constrained public finances, political cross-winds and rapid technological change. When health systems fail to adapt to such shocks, outcomes suffer: preventable illness rises, medical bills swell and public trust erodes. This puts stress on economies, governments and broader society.
However, these pressures create an opportunity to introduce and scale major innovations in health systems—new technologies, healthcare ventures, policies, programmes, interventions and novel financing and institutional arrangements. This could give rise to high-value health systems (HVHS) that are capable of creating measurable value at the national/state level. Governments, payers and providers must reorient their current strategies and develop a way of collaborating that enables innovation building, capture and scale-up in health systems. This should include exnovation: the elimination of inefficient policies, programmes, practices and technologies.

Value in the context of health systems refers to the net benefit produced for individuals and societies relative to the resources consumed in the production of health services. Assessment of value requires measuring system-level outcomes—including the level and distribution of health, financial risk protection and user satisfaction—in relation to the cost of providing health services. Health services include both individual health services, such as the medical care delivered to patients for specific diseases, and public health services, which include health promotion, prevention and protection. Health services produce value along four dimensions: effectiveness and efficiency, which produce “value for money”and equity and responsiveness, which lead to “value for many”. Each of these dimensions is measurable using standardised indicators for specific health services. Cancer survival, length of hospital stay and waiting time to see a specialist, for instance, may be used to assess the ‘effectiveness’, ‘efficiency’ and ‘responsiveness’ of oncology health services for different types of cancers.
The Health Systems Innovation Lab at Harvard University identified 10 High-Value components that countries should prioritise (Figure 1) for investment in order to transition to a high value health system to generate value at scale. Research examining the transition towards the HVHS model in G20+ nations found that most countries are implementing at least a subset of the ten components, but none have advanced substantially across the entire set.
Figure 1: The 10 Components Comprising a High Value Health System
Defining the 10 High-Value Health System Components
1. Digital data systems
Digital data systems enable the standardisation, collection, reporting, pooling and integration of different types of health data from different stakeholders in the system. This facilitates analyses and the delivery of health services, and informs evidence-based decision-making.
2. Analytics
Health analytics leverage advanced data science techniques, machine learning and artificial intelligence (AI) to generate insights from the data generated by data systems.
3. Cost measurement systems
These systems integrate with digital data systems to standardise and automate the collection, reporting and pooling of health costing and expenditure data.
4. Outcome measurement systems
These systems integrate with digital data systems to standardise and automate the collection, reporting and pooling of Patient-Reported Outcomes and Experience data.
5. Benchmarking
Benchmarking uses digital data systems and analytics to examine health system performance in a given country in relation to health system outcomes, objectives, outputs, functions and contextual shifts influencing performance and value creation across regional jurisdictions and public and private sectors.
6. Integrated care pathways
Integrated care pathways standardise and bundle evidence-based services across providers to reduce unwarranted variation and deliver high-value care journeys.
7. Value-based payment models
Value-based payment models reward providers for measured health outcomes and cost efficiency, aligning incentives among payers, providers and patients.
8. Value-based procurement
Value-based procurement shifts purchasing decisions away from measuring volumes of products to contracting for outcomes that meet the needs of patients, providers, payers and regulators.
9. Integrated provider networks
Integrated provider networks coordinate care across institutions and actors (providers and payers), sectors (public and private) and different levels of the health system to deliver seamless, pathway-based health services.
10. Strategic change and innovation ecosystem
A strategic change and innovation ecosystem creates the institutional, financial, political and partnership conditions that accelerate HVHS transformation.

Most initiatives aiming to generate value originate within single departments or institutions, but rarely expand to wider health networks or the national level. This underscores the gap between promising pilots, which often fail to progress past this stage, and system-level scale that benefits a nation. Component ten—the creation of a strategic change and innovation ecosystem that links the other nine components—is nascent in nearly all countries. Partial efforts to develop such ecosystems exist, but no jurisdiction yet operates a fully integrated, system-wide engine for venture-building, innovation, policy alignment and diffusion.
However, the opportunities to create HVHS are clear. “Getting It Right First Time (GIRFT)” in the United Kingdom, expanded a specialty audit in orthopaedics from one hospital department to a nationwide programme across 40 clinical disciplines. GIRFT demonstrates how benchmarking across National Health Insurance Trusts (component five) can reduce unwarranted variation in health service delivery, identify high vs low performing providers and drive improvements in health outcomes and cut costs at the national level. The Ayushman Bharat Digital Mission in India is investing in digital data systems (component one) and digital infrastructure that will enable other HVHS components, including analytics, cost measurement, outcome measurement, payment reform and integrated provider networks for nearly one billion people. By using a two-stage, outcome-centred dialogue process to assess vendor contracts for its Cardiology service, Ontario’s Southlake Regional Health Centre demonstrates how value-based procurement (component eight) can enhance health service effectiveness, efficiency and responsiveness measured in terms of heart-failure readmissions, length of stay and clinic wait-times.
A health systems innovation strategy is required to design, introduce and scale high-value innovations and transition from small-scale demonstration projects to system-wide initiatives that deliver impact for a nation. We propose three strategic innovation pathways (Figure 2) countries could pursue when introducing and scaling up high value innovations: (I) Expansion of a high-value innovation by geographical scale once proof of concept is demonstrated, for instance, from a clinical department to the institutional level, before incorporating additional HVHS components; (II) Extension of a high-value innovation by incorporating additional HVHS components once proof of concept is demonstrated, such as building an analytics layer using digital data systems at the department level, before expanding to the institutional level; and (III) Transformation, which pursues a combination of both scale and scope and introduces system-level policies that create an enabling innovation ecosystem for rapid introduction and scale-up of high-value innovations in health systems. Countries can sequence these pathways or pursue an optimal strategy that combines all three, depending on institutional readiness, fiscal space expansion and political capital for health system innovation.

Figure 2: Three Strategic Innovation Pathways to Transition to a High Value Health System
Each of these strategies create major opportunities for payers, providers, policymakers and innovators to identify areas of common ground, engage in strategic public-private partnerships and achieve shared value. Payers could prioritise analytics, benchmarking and value-based payment to link measurable outcomes with the total cost of care and engage providers based on performance. Providers, on the other hand, could invest in digital data systems, analytics, integrated care pathways and networks that enhance provider organization and interaction around more efficient clinical workflows and that enable outcome accountability. Policymakers should provide the leadership that enables cooperation between providers and payers and spearhead value-based procurement and a strategic change and innovation ecosystem. Innovators and entrepreneurs should use the components as a framework to inform startup ideas and venture building.
Accelerating the transition to HVHS is both an economic and political imperative. An explicit health system innovation strategy—whether for expansion, extension or transformation—provides a pragmatic route to better health, less public frustration and improved fiscal sustainability in all nations.
Disclosure statement: ‘Supported by The Cigna Group’ credit applies to Economist Enterprise only; the authors were not funded or otherwise supported by The Cigna Group.